Literature DB >> 7815505

Influenza B viruses with site-specific mutations introduced into the HA gene.

W S Barclay1, P Palese.   

Abstract

We have succeeded in engineering changes into the genome of influenza B virus. First, model RNAs containing the chloramphenicol acetyltransferase gene flanked by the noncoding sequences of the HA or NS genes of influenza B virus were transfected into cells which were previously infected with an influenza B helper virus. Like those of the influenza A viruses, the termini of influenza B virus genes contain cis-acting signals which are sufficient to direct replication, expression, and packaging of the RNA. Next, a full-length copy of the HA gene from influenza B/Maryland/59 virus was cloned. Following transfection of this RNA, we rescued transfectant influenza B viruses which contain a point mutation introduced into the original cDNA. A series of mutants which bear deletions or changes in the 5' noncoding region of the influenza B/Maryland/59 virus HA gene were constructed. We were able to rescue viruses which contained deletions of 10 or 33 nucleotides at the 5' noncoding region of the HA gene. The viability of these viruses implies that this region of the genome is flexible in sequence and length.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7815505      PMCID: PMC188703     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome.

Authors:  N Iizuka; M Kohara; K Hagino-Yamagishi; S Abe; T Komatsu; K Tago; M Arita; A Nomoto
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

2.  The deletion of 41 proximal nucleotides reverts a poliovirus mutant containing a temperature-sensitive lesion in the 5' noncoding region of genomic RNA.

Authors:  S L Dildine; B L Semler
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase.

Authors:  M W Shaw; P W Choppin; R A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

4.  Promoter analysis of influenza virus RNA polymerase.

Authors:  J D Parvin; P Palese; A Honda; A Ishihama; M Krystal
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

5.  Segment-specific and common nucleotide sequences in the noncoding regions of influenza B virus genome RNAs.

Authors:  M Y Stoeckle; M W Shaw; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains.

Authors:  M Krystal; J F Young; P Palese; I A Wilson; J J Skehel; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

7.  The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity.

Authors:  U Desselberger; V R Racaniello; J J Zazra; P Palese
Journal:  Gene       Date:  1980-02       Impact factor: 3.688

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  Influenza B virus genome: assignment of viral polypeptides to RNA segments.

Authors:  V R Racaniello; P Palese
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

10.  Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells.

Authors:  J L Schulman; P Palese
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

View more
  17 in total

Review 1.  Negative-strand RNA viruses: genetic engineering and applications.

Authors:  P Palese; H Zheng; O G Engelhardt; S Pleschka; A García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

2.  Segment-specific noncoding sequences of the influenza virus genome RNA are involved in the specific competition between defective interfering RNA and its progenitor RNA segment at the virion assembly step.

Authors:  T Odagiri; M Tashiro
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  The N-terminal extension of the influenza B virus nucleoprotein is not required for nuclear accumulation or the expression and replication of a model RNA.

Authors:  M P Stevens; W S Barclay
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  Influenza B and C virus NEP (NS2) proteins possess nuclear export activities.

Authors:  J Paragas; J Talon; R E O'Neill; D K Anderson; A García-Sastre; P Palese
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Influenza A virus NEP (NS2 protein) downregulates RNA synthesis of model template RNAs.

Authors:  R Bullido; P Gómez-Puertas; M J Saiz; A Portela
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.

Authors:  Caroline Goujon; Michael H Malim
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

7.  A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA.

Authors:  David Jackson; Andrew Cadman; Thomas Zurcher; Wendy S Barclay
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  Rescue of influenza B virus from eight plasmids.

Authors:  Erich Hoffmann; Kutubuddin Mahmood; Chin-Fen Yang; Robert G Webster; Harry B Greenberg; George Kemble
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

9.  A plasmid-based reverse genetics system for influenza A virus.

Authors:  S Pleschka; R Jaskunas; O G Engelhardt; T Zürcher; P Palese; A García-Sastre
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Mutational analysis of influenza B virus RNA transcription in vitro.

Authors:  Y S Lee; B L Seong
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.